Biosimilars in Juvenile Arthritis Management: C...

By Charmi Patel

July 16, 2024

Introduction Juvenile idiopathic arthritis (JIA) presents complex treatment challenges, often requiring a shift from traditional therapies to biological interventions when initial approaches prove insufficient. With conventional treatmen...
Enhancing Early Diagnosis and Care for Juvenile Idiopathic Arthritis
Enhancing Skin Cancer Prevention in a Primary Care Setting
Tuberculosis Care in Indonesia: A Financial Analysis of Strategic Purchasing ...
Striking the Balance: Optimising Hepatitis B Treatment Strategies in The Gambia
Cost-Utility and Cost-Effectiveness of Disease-Modifying Drugs for Relapsing-...
Introducing GRACE for Patient-Centric Care
The Impact of Time Horizons on QALY Calculations in Healthcare
Healthcare Decision-Making with MCDA Framework: The Saudi Arabian Perspective
Prevention is Better Than Cure: The Costs of the Pandemic Accord
Economic Evaluations for Dementia Interventions
Health equity insights for National Cancer Survivors Day
An Era of Equitable Access: The Potential of the Pandemic Accord